Role of STIM1 in E. coli Pneumonia
STIM1 在大肠杆菌肺炎中的作用
基本信息
- 批准号:8815359
- 负责人:
- 金额:$ 20.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-12-01 至 2016-11-30
- 项目状态:已结题
- 来源:
- 关键词:1,2-diacylglycerolAgonistAlcoholismAlveolarAlveolar MacrophagesAlveolitisAutoimmune hemolytic anemiaBackBacteriaBindingBronchoalveolar Lavage FluidCCAAT-Enhancer-Binding ProteinsCCL2 geneCa(2+)-Transporting ATPaseCalciumCalcium ChannelCell membraneCell modelCell physiologyCellsChronic Obstructive Airway DiseaseClinicalCommunitiesDataDental EnamelDevelopmentDiabetes MellitusDiglyceridesDiseaseEndoplasmic ReticulumEpithelial CellsEscherichia coliEscherichia coli InfectionsG Protein-Coupled Receptor GenesGene DeletionGene ExpressionGenetic studyHepatosplenomegalyHomeostasisHost DefenseHumanHydrolysisImmuneImmune responseImmunityImmunocompetentImmunocompromised HostImmunologic Deficiency SyndromesIndividualInfectionInflammationInflammatoryInflammatory ResponseInterleukin-6Ion Channel ProteinKnowledgeLungLung InflammationMediatingMediator of activation proteinMembraneMolecularMorbidity - disease rateMusMuscle hypotoniaMyelogenousMyeloid CellsNosocomial pneumoniaPathogenesisPatientsPhosphatidylinositol 4,5-DiphosphatePlayPneumoniaPoint MutationProteinsPumpRecruitment ActivityRoleSTIM1 geneSignal TransductionSignaling MoleculeSiteStimulusSystemTestingThrombocytopeniaToll-like receptorsWorkbasedesignextracellularhuman STIM1 proteinin vivoinflammatory lung diseaselung injurymacrophagemortalityneutrophilnew therapeutic targetnovelpostnatalprotein activationpublic health relevancereceptorrecombinaseresponsesensortranscription factor
项目摘要
DESCRIPTION (provided by applicant): Escherichia coli (E. coli) is one of the major causes of nosocomial pneumonia. Moreover, E. coli pneumonia may also be community-acquired in patients who have underlying disease such as diabetes mellitus, alcoholism, and chronic obstructive pulmonary disease. Although inappropriate inflammatory host responses play a central role in the pathogenesis of pneumonia, the precise molecular mechanisms underlying the development of this disorder remain poorly understood. Altered calcium homeostasis is considered to play an important role in inflammation. Although the predominant mechanisms to raise intracellular calcium used by most immune cells is store-operated Ca2+ entry (SOCE) whereby the depletion of endoplasmic reticulum (ER) Ca2+ stores triggers the influx of extracellular Ca2+, the direct molecular basis of SOCE activation was unknown until the recent identification of stromal interaction molecule 1 (STIM1) as the critical ER Ca2+ sensor. However, the significance of STIM1 and SOCE in in vivo inflammatory responses, immunity to infection, and other immune-related diseases remains largely unknown. Using the Cre recombinase-loxP system, we recently generated mice with specific deletion of the gene encoding STIM1 in myeloid cells (STIM1-/-). Our preliminary data indicate that STIM1 deficiency significantly reduced E. coli-induced IL-6, KC, IL-1b, and MCP-1 levels in bronchoalveolar lavage (BAL) fluids and neutrophil accumulation in the lung compared to WT mice (STIM1+/+). Furthermore, E. coli-stimulated STIM1-/- mice showed significantly reduced lung transcription factors CCAAT/enhancer-binding proteins (C/EBPs) activation (mainly C/EBP�). We further show that STIM1 interacts with Orai1 and TRPC1, important Ca2+ channels for SOCE in immune cells. Based on these studies, we hypothesize that STIM1 plays an important regulatory role in lung inflammatory responses to E. coli and host defense against E. coli pneumonia by interacting with Orai1, TRPC1, and other signaling molecules. Therefore, this exploratory study is designed to define the roles of STIM1 in E. coli- induced pulmonary alveolitis and the underlying molecular mechanisms. Two specific aims are proposed to test our hypothesis. In the first aim, we will determine the role of STIM1 in the lungs against E. coli infection. In the second aim, we will elucidate the molecular mechanisms of STIM1 function in the E. coli pneumonia. The results of our studies are expected to provide important novel information on the regulatory roles of STIM1 in the lung inflammatory responses to bacteria. This knowledge will represent a new paradigm for approaching the development of novel therapeutic targets for treatment of pneumonia.
性状(由申请人提供):大肠杆菌(E.大肠杆菌)是医院内肺炎的主要原因之一。此外,E.大肠杆菌肺炎也可能是社区获得性的患者谁有潜在的疾病,如糖尿病,酗酒,慢性阻塞性肺病。虽然不适当的炎症宿主反应在肺炎的发病机制中起着核心作用,但这种疾病发展的确切分子机制仍然知之甚少。钙稳态改变被认为在炎症中起重要作用。尽管大多数免疫细胞使用的提高细胞内钙的主要机制是钙库操纵的钙内流(SOCE),其中内质网(ER)钙库的耗尽触发细胞外钙的内流,但是直到最近鉴定基质相互作用分子1(STIM 1)作为关键的ER钙传感器,SOCE激活的直接分子基础才被知晓。然而,STIM 1和SOCE在体内炎症反应、感染免疫和其他免疫相关疾病中的重要性在很大程度上仍然未知。使用Cre重组酶-loxP系统,我们最近产生了骨髓细胞中编码STIM 1的基因特异性缺失的小鼠(STIM 1-/-)。我们的初步数据表明,STIM 1缺陷显着降低E。与WT小鼠(STIM 1 +/+)相比,支气管肺泡灌洗液(BAL)中大肠杆菌诱导的IL-6、KC、IL-1b和MCP-1水平以及肺中的中性粒细胞蓄积。此外,E.大肠杆菌刺激的STIM 1-/-小鼠显示肺转录因子CCAAT/增强子结合蛋白(C/EBP)激活(主要是C/EBP)显著减少。我们进一步表明,STIM 1与Orai 1和TRPC 1相互作用,这是免疫细胞中SOCE的重要Ca 2+通道。基于这些研究,我们推测STIM 1在E.大肠杆菌和宿主对E.大肠杆菌肺炎通过与Orai 1,TRPC 1和其他信号分子相互作用。因此,本研究旨在探讨STIM 1在大肠杆菌中的作用。大肠杆菌致肺泡炎的分子机制。提出了两个具体的目标来检验我们的假设。在第一个目标中,我们将确定STIM 1在肺中对抗E.大肠杆菌感染。第二个目标是阐明STIM 1在大肠杆菌中的分子机制。大肠杆菌肺炎。我们的研究结果有望为STIM 1在细菌致肺部炎症反应中的调节作用提供重要的新信息。这些知识将代表一种新的范式,用于接近开发新的治疗靶点治疗肺炎。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hongwei Gao其他文献
Hongwei Gao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hongwei Gao', 18)}}的其他基金
STAT3 and its Acetylation in Acute Lung Injury
STAT3 及其乙酰化在急性肺损伤中的作用
- 批准号:
7837554 - 财政年份:2009
- 资助金额:
$ 20.78万 - 项目类别:
STAT3 and its Acetylation in Acute Lung Injury
STAT3 及其乙酰化在急性肺损伤中的作用
- 批准号:
8107562 - 财政年份:2008
- 资助金额:
$ 20.78万 - 项目类别:
STAT3 and its Acetylation in Acute Lung Injury
STAT3 及其乙酰化在急性肺损伤中的作用
- 批准号:
7898760 - 财政年份:2008
- 资助金额:
$ 20.78万 - 项目类别:
STAT3 and its Acetylation in Acute Lung Injury
STAT3 及其乙酰化在急性肺损伤中的作用
- 批准号:
8321531 - 财政年份:2008
- 资助金额:
$ 20.78万 - 项目类别:
STAT3 and its Acetylation in Acute Lung Injury
STAT3 及其乙酰化在急性肺损伤中的作用
- 批准号:
7661377 - 财政年份:2008
- 资助金额:
$ 20.78万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 20.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 20.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 20.78万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 20.78万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 20.78万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 20.78万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 20.78万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 20.78万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 20.78万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 20.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




